Three different dogs who had immune-mediated hemolytic anemia (IMHA) were treated for more than two weeks with blood transfusion in an animal clinic. Despite this treatment and hospitalization, there was no clinical improvement in clinical signs as well as complete blood cell count (CBC) including hematocrit (HCT) and C-reactive protein (CRP). All cases were then injected two or three times with allogeneic stem cells through an intravenous route for treatment. Upon administrating stem cells to the IMHA dogs, clinical conditions and the indexes of HCT and CRP were clinically improved within or close to normal ranges.

INTRODUCTION
CASE
DISCUSSION
CONCLUSION
REFERENCES

• Yeonmi Lee(Department of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea)
• Eunju Kang(Department of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea)
• Junguk Ju(AniCom Therapeutics Inc., Seoul 04599, Korea, AniCom Medical Center, Animal Hospital, Seoul 04599, Korea) Corresponding author